Real Estate · Lessors of Real Property, NEC · OTC · CIK 1004724 · FYE Dec 31 · Prices AT CLOSE 2026-07-28 (USD) — end-of-day, never a live or intraday quote
Last $1.05Day +2.68%Mkt cap $4MP/E (FY) 1.0×1Y −68.4%Off 52W high −70.9%Vol (1Y) 81.0%
Daily closing price, split-adjusted to the current basis; 1.4y shown of 360 bars on file. Sampled to 240 points — every point is a real close, none averaged. Price return, not total return (dividends excluded). Source marketstack.
| Short interest0.2% of sh out |
| Days to cover1.0d |
| Next report (est.)2026-08-14 |
Short interest is FINRA semi-monthly, settlement 2026-07-15.
| P/E (FY)1.0× |
| Sales (TTM)$67.1M |
| Earnings (TTM)$3.4M |
| Net margin6.3% |
| Debt / equity115.05× |
| Total debt / EBITDA10.77× |
| Sales growth 3Y14.0% |
Screener basis: ratios from the latest reported fiscal year; Sales/Earnings are trailing twelve months in the reporting currency (USD). The P/E is a trailing FULL-YEAR P/E, not TTM. Missing lines are absent from the filings, never imputed.
| YTD−18.2% |
| 1Y−68.4% |
| Since incept. (ann.)−41.7% |
Total return through 2026-07-28 · series begins 2025-02-05. Only the windows this history actually covers are shown.
| Ann. volatility (1Y)81.0% |
| Ann. volatility (3Y)120.8% |
| Sharpe (1Y)−1.07 |
| Sharpe (3Y)0.14 |
| Max drawdown (1Y)−69.5% |
| Max drawdown (3Y)−69.9% |
| Beta (3Y vs SPY)−1.63 |
Daily simple returns, annualized; drawdown is peak-to-trough within the window. Beta is the OLS slope of monthly returns on SPY's over three years. Each figure is labeled by the window it was measured over — they are not comparable across windows.
No 13F holders on file for RHEP.
| Period end | Reported | EPS | EPS YoY | Revenue | Rev YoY |
|---|---|---|---|---|---|
| 2026-03-31 | 2026-05-15 | −$0.29 | — | $21.2M | +194.3% |
| 2025-12-31 | 2026-04-02 | — | — | $20.8M | +267.2% |
| 2025-09-30 | 2025-11-14 | $1.17 | — | $15.1M | +258.3% |
| 2025-06-30 | 2025-08-14 | −$0.68 | — | $10.1M | +132.5% |
EPS and revenue as reported in this filer's own XBRL — our extraction of the filings, not a vendor consensus feed, and never a beat/miss claim (we carry no estimates). YoY compares the same fiscal quarter a year earlier. Next report 2026-08-14 is ESTIMATED from filing cadence (median gap 91d) — not company-confirmed.
Healthcare Services 68% · Pharmacy Service 22% · Real Estate 10%
business segments · each slice's share of TAGGED segment revenue in the latest annual filing (XBRL, as filed). Untagged revenue is excluded from the denominator, so slices need not sum to consolidated sales.
